Alterity Therapeutics ATHE
NASDAQ ATHE
$4.58 +0.13 (+2.97%)
As of: Aug 21, 2026 · 2:42 PM EDT

Alterity Therapeutics (ATHE) FCF Margin Growth (3y) (2019)

Alterity Therapeutics (ATHE) FCF Margin Growth (3y) (2019) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 138.60 Bn 130.75 Bn 2.84 Bn -1,272.00
2 Regeneron Pharmaceuticals 85.93 Bn 77.93 Bn 3.93 Bn -2,228.00
3 Argenx Se 65.06 Bn 59.88 Bn 1.37 Bn -
4 Moderna 56.22 Bn 51.08 Bn 52.00 Mn -5,426.00
5 BeOne Medicines 42.03 Bn 36.93 Bn 1.53 Bn 9,545.00
6 Alnylam Pharmaceuticals 31.65 Bn 28.34 Bn 992.69 Mn 4,612.00
7 BioNTech SE 27.70 Bn 9.31 Bn 668.28 Mn 1,850.00
8 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 14,060.00
9 Royalty Pharma 27.31 Bn 26.48 Bn - -3,088.00
10 Alterity Therapeutics 48.83 Mn 16.53 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2019 17,319.00